Phase 2 Oesophageal Cancer Trial, Recruiting NCT03964753 Sponsor: Hebei Medical University Fourth Hospital Condition: Oesophageal Cancer
Back to Oesophageal Cancer

Phase 2 Oesophageal Cancer Trial, Recruiting

NCT03964753
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You have been diagnosed with squamous cell carcinoma (a specific type of cancer) in the middle or lower part of the esophagus (food pipe), confirmed by scans, tissue sample, or fluid sample, and the cancer has not spread to distant parts of the body
  • Scans show the tumor may be removable by surgery, with no signs of it growing into surrounding chest structures or into the airways
  • You have never had any previous treatment for esophageal cancer, including radiation, chemotherapy, targeted therapy, or immunotherapy
  • You are generally able to carry out daily activities with little to no limitation (confirm with trial site)
  • You are expected to live for more than 6 months
  • Your organ function tests show no reasons that would prevent surgery
  • Your blood test results meet specific requirements for bone marrow, liver, kidney, and blood clotting function (confirm with trial site for exact values)
  • If you are a woman who could become pregnant, you agree to use effective birth control during the study and for 6 months after it ends, have a negative pregnancy test within 7 days before joining, and are not breastfeeding; if you are a man, you also agree to use effective birth control during the study and for 6 months after it ends
  • You do not have any other serious uncontrolled illness, such as an active infection in the kidneys, lungs, or liver
  • You have not been part of another clinical trial in the 4 weeks before starting treatment
  • You are willing and able to follow the study plan, understand what the study involves, and sign a consent form

Who may not be able to join:

  • Your esophageal cancer has been confirmed as adenocarcinoma (a different type of esophageal cancer)
  • Your cancer has spread to distant parts of the body and cannot be fully removed by surgery
  • You have taken other medications (including traditional herbal medicines) before joining, or there are concerns you may not be able to follow the study requirements
  • You have moderate or severe nerve damage or bleeding problems (confirm with trial site)
  • You have serious heart or blood pressure problems, including uncontrolled high blood pressure, unstable chest pain, a heart attack in the past 6 months, significant heart failure, severe irregular heartbeat, or fluid around the heart
  • You have a severe hormone condition affecting fluid balance, or diabetes that is very difficult to control despite high doses of insulin or with very high blood sugar levels (confirm with trial site)
  • You have been taking blood-thinning medications such as warfarin or heparin long-term for more than 6 months (low-dose warfarin or aspirin taken for prevention purposes may be acceptable — confirm with trial site)
  • You have had major surgery within the 4 weeks before joining, or your surgical wounds have not fully healed
  • Previous stomach surgery means your stomach cannot be used to rebuild your digestive tract after esophageal surgery
  • You have had a serious infection in the week before starting the study that required intravenous antibiotics, antifungal, or antiviral treatment
  • You are known to be allergic or highly sensitive to any of the drugs or ingredients used in this study
  • You have had another type of cancer in the past 5 years (certain skin cancers and early-stage cervical cancer may be exceptions — confirm with trial site)
  • Any test result shows that chemotherapy or surgery would not be safe for you
  • You are pregnant or breastfeeding
  • The study doctor decides that medical, social, or psychological reasons would prevent you from completing the study, or you are unable to give valid informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 13931152296

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Hebei Medical University Fourth Hospital
Registry
ClinicalTrials.gov
Start date
24 April 2019
Est. completion
24 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

OS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov